December 22, 2021
3,448
56
14
2.03%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
1:31Now PlayingOn Dec. 20, the FDA approved a new drug called Apretude.
The drug will be used as pre-exposure prevention (PrEP) against HIV. The long-acting injectable medication is the first of its kind. Apretude is given every two months as opposed to pills like Truvada and Descovy, which are taken daily.
To watch BNC programming, visit
Follow BNC on social media:
#FDA #PrEP #HIV
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.